文献速递生殖医学母胎医学

序贯胚胎活检中新发节段性非整倍体的持续性

Permanence of de novo segmental aneuploidy in sequential embryo biopsies.
PubMed 文献 · Hum Reprod · 2020-01-01

该回顾性研究分析342个PGT-A周期中2082份样本,发现新发节段性非整倍体(SA)在卵母细胞中发生率6.3%,卵裂期胚胎升至16.6%,囊胚降至11.2%,囊胚液中最高达26.1%。66组序贯活检中59.1%完全一致,支持SA多为生物学事件而非技术假象。

要点

  • SA在卵裂期胚胎发生率最高(16.6%),囊胚液检出率可达26.1%。
  • 59.1%的序贯活检组SA诊断完全一致,持续至囊胚阶段。
  • 18.2%的组别在任何阶段均未确认初始SA,对应染色体为整倍体。

核心结论

  • 序贯活检中SA的持续存在支持其生物学性质,而非单纯技术假象。

研究设计与样本

  • 回顾性研究纳入2014年1月至2018年12月342个PGT-A周期,共分析2082份样本(331卵母细胞、886卵裂期胚胎、570囊胚及268份囊胚液)。

主要发现

  • SA发生率在卵母细胞为6.3%,卵裂期胚胎为16.6%(P < 0.001 vs 卵母细胞),囊胚为11.2%(P < 0.025 vs 卵母细胞;P < 0.01 vs 卵裂期胚胎),囊胚液为26.1%(P < 0.001)。
  • 66组序贯活检中,39组(59.1%)所有后续样本均确认初始SA,12组(18.2%)部分样本检出SA而另一些样本对应染色体完全非整倍体,3组(4.5%)部分一致但所有TE样本对应染色体为整倍体,12组(18.2%)任何阶段均未确认SA。
  • 一致模式不受初始活检中SA数目(单发、双发或复杂)或是否伴发完全染色体非整倍体的影响。

临床怎么用

  • 对涉及丢失或获得超过15 Mb的SA胚胎不予移植,并在后续阶段进行序贯活检。
  • 由于数据有限,携带SA胚胎的移植应严格随访以明确临床后果。

局限性

  • 染色体分析基于活检样本,可能因嵌合体而不能代表胚胎真实构成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is de novo segmental aneuploidy (SA) a biological event or an artifact that is erroneously interpreted as partial chromosome imbalance? SUMMARY ANSWER: The detection of de novo SA in sequential biopsies of preimplantation embryos supports the biological nature of SA. WHAT IS KNOWN ALREADY: Although some SAs are detected in oocytes and in blastocysts, the highest incidence is observed in cleavage-stage embryos. Based on these findings, we can postulate that the majority of cells affected by SAs are eliminated by apoptosis or that affected embryos mainly undergo developmental arrest. STUDY DESIGN, SIZE, DURATION: This retrospective study includes 342 preimplantation genetic testing for aneuploidy (PGT-A) cycles performed between January 2014 and December 2018. Chromosome analysis was performed on 331 oocytes, 886 cleavage-stage embryos and 570 blastocysts (n = 1787). From 268 expanded blastocysts, the blastocoelic fluid (BF) was also analyzed (resulting in 2025 samples in total). In cases of SAs involving loss or gain in excess of 15 Mb, embryos were not considered for transfer and sequential biopsies were performed at following stages. This resulted in 66 sets where the initial diagnosis of SAs (4 made in polar bodies, 25 in blastomeres and 37 in trophectoderm (TE) cells) was followed up. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 2082 samples (2025 + 27 whole embryos) were processed by whole genome amplification followed by array comparative genomic hybridization. MAIN RESULTS AND THE ROLE OF CHANCE: The incidence of SAs was 6.3% in oocytes, increased to 16.6% in cleavage-stage embryos (P < 0.001) and decreased to 11.2% in blastocysts (P < 0.025 versus oocytes; P < 0.01 versus cleavage-stage embryos). The highest incidence of SAs was found in BFs (26.1%, P < 0.001). The analysis of 66 sets of sequential biopsies revealed that the initial finding was confirmed in all following samples from 39 sets (59.1% full concordance). In 12 additional sets, SAs were detected in some samples while in others the interested chromosome had full aneuploidy (18.2%). In three more sets, there was a partial concordance with the initial diagnosis in some samples, but in all TE samples the interested chromosome was clearly euploid (4.5%). In the remaining 12 sets, the initial SA was not confirmed at any stage and the corresponding chromosomes were euploid (18.2% no concordance). The pattern of concordance was not affected by the number of SAs in the original biopsy (single, double or complex) or by the absence or presence of concomitant aneuploidies for full chromosomes. LIMITATIONS, REASONS FOR CAUTION: Chromosome analyses were performed on biopsies that might not be representative of the true constitution of the embryo itself due to the occurrence of mosaicism. WIDER IMPLICATIONS OF THE FINDINGS: The permanence of SAs throughout the following stages of embryo development in more than half of the analyzed sets suggests for this dataset a very early origin of this type of chromosome imbalance, either at meiosis or at the first mitotic divisions. Since SAs remained in full concordance with the initial diagnosis until the blastocyst stage, a corrective mechanism seems not to be in place. In the remaining cases, it is likely that, as for full chromosome aneuploidy, mosaicism derived from mitotic errors could have occurred. In following cell divisions, euploid cell lines could prevail preserving the embryo chances of implantation. Due to the scarcity of data available, the transfer of embryos with SAs should be strictly followed up to establish possible clinical consequences related to this condition. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was obtained. There are no conflicts of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Magli MC, Albanese C, Crippa A, et al. Permanence of de novo segmental aneuploidy in sequential embryo biopsies. Hum Reprod. 2020. PMID: 32242613. doi:10.1093/humrep/deaa025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。